Recursion Pharmaceuticals
RXRX
#3731
Rank
NZ$4.81 B
Marketcap
$12.39
Share price
-4.30%
Change (1 day)
-18.58%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.74 Billion

According to Recursion Pharmaceuticals's latest financial reports the company has NZ$0.74 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Recursion Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.61 B-28.51%
2022-12-31NZ$0.86 B14.53%
2021-12-31NZ$0.75 B108.17%
2020-12-31NZ$0.36 B250.11%
2019-12-31NZ$0.10 B